WallStreetZenWallStreetZen

NASDAQ: VCRE
Vicore Pharma Holding Ab Revenue

OverviewEarningsRevenue
DividendOwnership
Vicore Pharma Holding Ab revenue was N/A for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $64.4k, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, VCRE annual revenue was $414.9k, with -95.8% growth year-over-year.

VCRE revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

Be the first to know when VCRE announces revenue.

VCRE Revenue History By Year

VCRE Yearly RevenueVCRE RevenueVCRE ChangeVCRE Revenue Growth
2025-12-31$414.89k-$9.50M-95.81%
2024-12-31$9.91MN/AN/A
2023-12-31$0.00N/AN/A

1 of 1

Vicore Pharma Holding Ab Revenue FAQ

What was VCRE's revenue last quarter?

Vicore Pharma Holding Ab (NASDAQ: VCRE) reported Q1 2026 revenue of $64.39 thousand up 27.82% year over year. In the same quarter last year, Vicore Pharma Holding Ab's revenue was $89.20 thousand.

What was Vicore Pharma Holding Ab's revenue in 2025?

Vicore Pharma Holding Ab's annual revenue for the twelve months ending Dec 31, 2025 was $414.89 thousand, a 95.81% decrease year over year.

How much does Vicore Pharma Holding Ab make in a day?

Based on Vicore Pharma Holding Ab annual revenue for the past two years, VCRE makes an average of $14,148.49 per day.

What was Vicore Pharma Holding Ab's annual revenue growth in the past year?

As of Q3 2026, Vicore Pharma Holding Ab's revenue has grown null year over year. Vicore Pharma Holding Ab's revenue in the past year totaled N/A.

How much does Vicore Pharma Holding Ab make in a year?

Vicore Pharma Holding Ab's revenue by year for the past two years is:
  • Vicore Pharma Holding Ab's revenue for the twelve months ending Dec 31, 2025 was $414.89 thousand, a 95.81% decrease year over year.
  • Vicore Pharma Holding Ab's annual revenue for Dec 31, 2024 was $9.91 million, a Infinity% increase from 2023.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.